J Patrick Heron
Affiliations
- at Hillevax Inc. (HLVX), 2025-06-25
- at Arcutis Biotherapeutics Inc. (ARQT), 2025-06-17
- at Mbx Biosciences Inc. (MBX), 2025-06-06
- at Mirum Pharmaceuticals Inc. (MIRM), 2025-06-02
- Large Shareholder at Alpine Immune Sciences Inc. (ALPN), 2022-02-15
- Director at Imago Biosciences Inc. (IMGO), 2021-07-20
- Director at Vaxcyte Inc. (PCVX), 2021-06-03
- Director at Frazier Lifesciences Acquisition Corp (FLAC), 2020-12-17
- Large Shareholder at Tarsus Pharmaceuticals Inc. (TARS), 2020-10-21
- Director at Iterum Therapeutics Plc (ITRM), 2020-07-06
- Large Shareholder at Phathom Pharmaceuticals Inc. (PHAT), 2020-06-16
- Large Shareholder, Director at Passage Bio Inc. (PASG), 2020-03-03
- Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2020-01-13
- Large Shareholder at Aptinyx Inc. (APTX), 2018-06-26
- Large Shareholder at Anaptysbio Inc (ANAB), 2018-05-15
- Large Shareholder at Sierra Oncology Inc. (SRRA), 2017-02-24
- Director at Tobira Therapeutics Inc. (TBRA), 2016-11-03
- Large Shareholder, Director at Collegium Pharmaceutical Inc (COLL), 2015-09-14
- Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
- Director at Cidara Therapeutics Inc. (CDTX), 2015-04-22
- Director, Other at Trubion Pharmaceuticals Inc (TRBN), 2010-10-28
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ARQT | $13.08 | 2,646 | $34,610.47 | 27,448 | 2025-06-13 | Filing |
| ARQT | $13.41 | 378 | $5,069.28 | 24,802 | 2025-06-05 | Filing |
| ARQT | $13.32 | 1,890 | $25,177.45 | 24,424 | 2025-06-04 | Filing |
| ARQT | $13.65 | 2,520 | $34,398.00 | 22,534 | 2025-05-22 | Filing |
| ARQT | $13.66 | 2,520 | $34,423.20 | 20,014 | 2025-05-21 | Filing |